By Barak Cohen, Andrew Kline & Tommy Tobin May 27, 2022 On May 26, the FDA issued warning letters to four companies alleging that the companies sold unapproved animal drugs containing cannabidiol (CBD). Specifically, these products were intended for use in...
Jodi Green, Delfina Homen Miller Nash LLP In the first federal appellate ruling on delta-8 THC, the Ninth Circuit Court of Appeals deemed the substance legal—at least for purposes of trademark protection—concluding that if “Congress inadvertently created a loophole...
25 May 2022 by Mary Drabnis , Michael Schwegler and Heidi Urness McGlinchey Stafford In 1965, Bob Dylan sang in Subterranean Homesick Blues that “you don’t need a weatherman to know which way the wind blows.” Thanks to a May 19 decision from the Ninth Circuit, we...
May 26, 2022 Delta 8 tetrahydrocannabinol (“THC”), an intoxicating form of THC often derived from hemp-derived cannabidiol (aka “CBD”), has been at the center of numerous hot button issues since its arrival in the broader hemp product market last year. We have...
Date: May 25, 2022 Key Notes: The Ninth Circuit found that Delta-8 THC products are federally legal under the plain meaning of the definition of “hemp” set by the 2018 Farm Bill, making it the first Circuit to find such products lawful. The Ninth Circuit affirmed a...
May 25, 2022 By Daniel Shortt Federal Law & Policy, Hemp/CBD On May 19, 2022, the United State Court of Appeals for the Ninth Circuit (9th Circuit) ruled in a landmark case regarding the legality of delta-8 tetrahydrocannabinol (delta-8 THC). The...